LBT 0.00% 1.4¢ lbt innovations limited

Ann: LBT begins key U.S. trial of APAS technology, page-38

  1. 596 Posts.
    Any pathology product (like pharmaceuticals) must have demonstrated its efficacy before it can be sold.
    Without such a demonstration its unsaleable.
    The USA Food and Drug Administration (FDA) is the pre-eminent approval authority.
    If approval for a product is obtained through the FDA then approvals elsewhere will be much easier to obtain. It's like dominoes, knock one over and the rest will follow.
    I agree it's frustrating, because it's time consuming, but, like any company in the medical field nothing seems to be happening until approval is gained.

    Then there'll be movement at the station.
 
watchlist Created with Sketch. Add LBT (ASX) to my watchlist
(20min delay)
Last
1.4¢
Change
0.000(0.00%)
Mkt cap ! $23.13M
Open High Low Value Volume
1.3¢ 1.4¢ 1.3¢ $10.09K 728.0K

Buyers (Bids)

No. Vol. Price($)
5 4745520 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.4¢ 418800 1
View Market Depth
Last trade - 12.59pm 18/09/2024 (20 minute delay) ?
LBT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.